Neural Stem Cell Transplants Aid TBI Recovery
Author: Cell Transplantation Center of Excellence for Aging and Brain Repair
Synopsis and Key Points:
Treating traumatic brain injury with human neural stem cells increases M2 microglial proteins and contributes to anti-inflammatory effects.
Traumatic brain injury (TBI) is a major cause of mortality and morbidity, often causing lifelong disability for those who survive. Treatment is limited to supportive care, but stem cell therapy has received recent attention as a way to promote recovery for injuries to the central nervous system (CNS). In this study, researchers transplanted human neural stem cells (hNSCs) into the brains of mice modeled with TBI to investigate whether the hosts' immune systems and the stem cells acting in concert would enhance repair.
The researchers found that the transplanted hNSCs had a beneficial effect when the cells differentiated into a neuroprotective form (M2) of microglia (the main immune cells of the CNS) and subsequently reduced inflammatory responses generated by the injury.
Their study will be published in a future issue of Cell Transplantation and is currently freely available on-line as an unedited, early epub at: www.ingentaconnect.com/content/cog/ct/pre-prints/content-CT-1532_Gao_et_al
"Two types of stem cells have been tested in animal models of neurotrauma: mesenchymal stems cells (MSCs) and neural stem cells," explained Dr. Ping Wu of the Department of Neuroscience and Cell Biology at the University of Texas Medical Branch at Galveston. "The attractive feature of hNSCs is their unique nature of being committed to differentiation into neural cell lineages. We hypothesized that hNSC transplantation may provide several layers of benefits as a protective therapeutic strategy for brain injury by positively affecting the post-injury microenvironment and replacing lost neural cells."
The researchers reported that the animals receiving the hNSC transplantation showed "significantly reduced accumulation of amyloid precursor protein (APP)," an indicator of axonal injury. Most importantly, the researchers observed an increase in anti-inflammatory proteins of microglial cells of the protective M2 subtype.
"Our study confirmed the beneficial effect of hNSC transplantation for TBI and suggested that hNSCs have the ability to lessen the damage to neural cells, leading them to differentiate from the damaging M1 subtype into the neuroprotective M2 subtype," explained Wu. "The transition to M2 likely contributes to the neural repair effect of the grafted hNSCs."
The shift from M1 to M2 types is important because M1 cells and their associated cells are known to be toxic, while M2 promotes a regenerative response in the injured CNS.
The researchers also commented that they did not use immunosuppressive drugs following the cell transplantation and that hNSCs are known to be short-lived without immunosuppression, although they still lessened inflammatory responses. In conclusion they suggested that further studies that incorporate immunosuppression post-transplantation are needed to see if immunosuppression affects stem cell-mediated immunomodulation.
"Intracerebral transplantation of hNSCs efficiently leads host microglia/macrophages towards an anti-inflammatory phenotype that presumably contributes to stem cell-mediated neuroprotective effects after severe TBI in mice," concluded the researchers. "In future studies, it will be interesting to determine how cells in brain regions distant from the damage center respond to traumatic injury and cell grafting."
"Traumatic brain injury is a major area of concern for both clinicians and researchers and can result in devastating, debilitating effects for the patients," said Dr. Paul R. Sanberg, Center of Excellence for Aging and Brain Repair, Department of Neurosurgery and Brain Repair, Morsani College of Medicine, University of South Florida, Tampa, FL and Co-Editor-in-Chief for Cell Transplantation. "TBI affects many different groups within our society and, as such, new approaches are sorely needed. This study offers new, mechanistic insight into the efficacy of neural stem cell transplantation and the field of regenerative medicine as a whole. Future studies that help progress this treatment modality to the clinic are warranted."
Citation: Gao J, Grill RJ, Dunn TJ, Bedi S, Labastida JA, Hetz RA, Xue H, Thonhoff JR, DeWitt DS, Prough DS, Cox CS Jr, Wu, P. Human neural stem cell transplantation-mediated alteration of microglial/macrophage phenotypes after traumatic brain injury. Cell Transplant. Appeared or available on-line: March 14, 2016.
The Co-Editors-in-Chief for CELL TRANSPLANTATION are at the Department of Neurosurgery and Brain Repair, Morsani College of Medicine, University of South Florida, Tampa, FL, USA and the Center for Neuropsychiatry, China Medical University Hospital, TaiChung, Taiwan. Contact: Paul R. Sanberg at firstname.lastname@example.org, Shinn-Zong Lin at email@example.com, or Associate Editor Samantha Portis at firstname.lastname@example.org
Contact: Dr. Ping Wu, Department of Neuroscience and Cell Biology, University of Texas Medical Branch at Galveston, Texas, Galveston, TX 77555-0620
Tel: (409) 772-9858
Fax: (409) 747-0620
- 1: Videos Inspire Veterans and Service Members with TBI to Seek Help : Defense and Veterans Brain Injury Center (2016/01/05)
- 2: Teens with TBI History More Likely to Have Used Crystal Meth : St. Michael's Hospital (2014/11/27)
- 3: Brain's Ability to Heal Itself Research Offers Hope for TBI : Henry Ford Health System (2015/03/23)
- 4: Cell Pores Discovery: Hope for Millions of Brain and Spinal Cord Injury Patients : Aston University (2020/05/17)
- 5: Canadian Government National Guidelines for Concussion Management : Public Health Agency of Canada (2016/10/30)
- 6: Cervical Hernias Can Cause Brain Damage Research Reveals : Network of Valencian Universities for the promotion of Research (2020/01/17)
- 7: How the NFL Came to Shape the Concussion Issue That Plagued It : University of Michigan (2017/10/17)
• Disabled World is strictly a news and information website provided for general informational purpose only and does not constitute medical advice. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World. Please report outdated or inaccurate information to us.